ImmunityBio Shares Are Trading Higher on Continued Strength After the Company on Thursday Announced Insurance Coverage of ANKTIVA Across Multiple States With First Commercial Doses Administered.
ImmunityBio Shares Are Trading Higher on Continued Strength After the Company on Thursday Announced Insurance Coverage of ANKTIVA Across Multiple States With First Commercial Doses Administered.
保險業中免疫生物股份正在繼續增強，週四宣佈在多個州提供ANKTIVA的保險覆蓋後，首次商業劑量已經投放。
ImmunityBio Shares Are Trading Higher on Continued Strength After the Company on Thursday Announced Insurance Coverage of ANKTIVA Across Multiple States With First Commercial Doses Administered.
保險業中免疫生物股份正在繼續增強，週四宣佈在多個州提供ANKTIVA的保險覆蓋後，首次商業劑量已經投放。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。